The Abu Dhabi Investment Authority (ADIA) announced on Monday that it will acquire a 3% equity stake in Gujarat-based medical devices manufacturer Meril for $200 million (approximately ₹1,723 crore). A wholly owned subsidiary of ADIA has signed definitive agreements to execute the investment, which is currently awaiting clearance from the Competition Commission of India (CCI).
Valuation and Existing Backers
The deal values Meril at $6.6 billion (about ₹56,859 crore). Once completed, ADIA and Warburg Pincus will back Meril, further strengthening its financial and strategic positioning.
Meril’s Expanding Footprint in MedTech
Meril specializes in developing and manufacturing a wide range of medical technologies, including cardiovascular devices, structural heart solutions, surgical robotics, orthopaedic implants, in-vitro diagnostics, and endo-surgery tools. The company recently invested ₹1,400 crore in a state-of-the-art facility in Vapi, underlining its commitment to innovation and manufacturing excellence.
Leadership Welcomes Long-Term Backing
As reported by Business Standard, Sanjeev Bhatt, Senior Vice President for Strategy at Meril, welcomed the development and said, “The investment by ADIA reinforces confidence in Meril’s long-term vision and global ambitions. It will enable us to accelerate our growth, attract world-class talent, and further strengthen our R&D and clinical research efforts.”
Advancing Healthcare Through Innovation
With this investment, Meril aims to continue its mission of improving human life. The company focuses on delivering advanced healthcare solutions. The backing of globally trusted investors is expected to further fuel the company’s expansion in both domestic and international markets.